Cash Balance: Ended the year with $754 million in cash. Operating Expenses: 35% reduction in pro forma operating expenses year over year. 2026 Cash Operating Expenses: Expected to be under $390 ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2025 Earnings Call Transcript February 25, 2026 Recursion Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.20528, expectations ...

WASHINGTON — C-SPAN has addressed whether President Donald Trump called into the show last week under the pseudonym "John Barron." The rumors began to swirl last week following the Supreme Court's ...

President Donald Trump did not, in fact, call in to C-SPAN on Friday using “John Barron” as a fake name, the network said. A man who identified himself with that name called in to C-SPAN after the ...

Record Q4 results: SS&C reported adjusted revenue of $1.655 billion (up 8%), adjusted EPS of $1.69 (up 18%) and adjusted EBITDA of $651 million, and issued 2026 guidance of $6.65–$6.74 billion in ...

Chairman and Chief Executive Officer — William C. Stone President and Chief Operating Officer — Rahul Kanwar Chief Financial Officer — Brian Schell Head of Investor Relations — Justine Stone Colby: My ...

Abstract: The short packet transmission (SPT) has gained much attention in recent years. In SPT, the most significant characteristic is that the finite blocklength code (FBC) is adopted. With FBC, the ...